HP
KLDO

Harbourvest Partners’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Harbourvest Partners’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,833,832
Closed -$3.03M – 68
2022
Q1 		$3.03M Hold
1,833,832
– – 0.62% 23
2021
Q4 		$4.38M Hold
1,833,832
– – 0.56% 18
2021
Q3 		$10M Hold
1,833,832
– – 0.94% 13
2021
Q2 		$13.6M Hold
1,833,832
– – 1.3% 9
2021
Q1 		$14.9M Hold
1,833,832
– – 1.99% 8
2020
Q4 		$16.7M Sell
1,833,832
-86,195
-4% -$707K 6.52% 4
2020
Q3 		$23.4M Buy
1,920,027
+86,195
+5% +$597K 8.67% 2
2020
Q2 		$13.6M Buy
1,833,832
+666,666
+57% +$4.47M 5.87% 4
2020
Q1 		$7.18M Hold
1,167,166
– – 3.46% 4
2019
Q4 		$5.86M Hold
1,167,166
– – 2.41% 7
2019
Q3 		$8.79M Hold
1,167,166
– – 3.66% 4
2019
Q2 		$13.5M Hold
1,167,166
– – 4.96% 5
2019
Q1 		$16.9M Buy
+1,167,166
New +$16.1M 5.99% 3

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Harbourvest Partners's KLDO Position: Q2 2022 in Review

Harbourvest Partners sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 1,833,832 shares — an estimated $3.03M sold.

Harbourvest Partners first reported a position in KLDO in Q1 2019 and held it in 13 quarters. The position peaked at $23.4M in Q3 2020. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Harbourvest Partners reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Harbourvest Partners sold 1,833,832 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $3.03M.
  • Harbourvest Partners first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Harbourvest Partners's Kaleido Biosciences, Inc. Common Stock position peaked at $23.4M in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Harbourvest Partners's 13F filing for Q2 2022, filed 15 Aug 2022.